Salvage Therapy for Liver-dominant Colorectal Metastatic Adenocarcinoma: Comparison between Transcatheter Arterial Chemoembolization versus Yttrium-90 Radioembolization

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 3, 2009, Pages 360-367

  Hong, Kelvin ^a   McBride, Jeremy D ^a   Georgiades, Christos S ^a   Reyes, Diane K ^a   Herman, Joseph M ^a   Kamel, Ihab R ^a   Geschwind, Jean François H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CEFAZOLIN; CETUXIMAB; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IODINATED POPPYSEED OIL; IRINOTECAN; METRONIDAZOLE; MITOMYCIN; ONDANSETRON; OXALIPLATIN; POLYVINYL ALCOHOL; THERASPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; LIVER METASTASIS; LUNG EMBOLISM; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIOEMBOLIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 60649099351     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.11.019     Document Type: Article

References (36)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Weiss L., Grundmann E., Torhorst J., et al. Haematogenous metastasis patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150 (1986) 195-203
3. Tellez C., Benson A.B., Lyster M.T., et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82 (1998) 1250-1259
4. McMillan D.C., and McArdle C.S. Epidemiology of colorectal liver metastases. Surg Oncol 16 (2007) 3-5
5. Patel N.H., and Jindal R.M. The role of chemoembolization in the treatment of colorectal hepatic metastasis. Hepatogastroenterology 48 (2001) 448-452
6. Lewandowski R., Thurston K., Goin J., et al. 90Y microsphere (Therasphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by (18F) Fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16 (2005) 1641-1651
7. Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343 (2000) 905-914
8. Goldberg R.M., Sargent D.J., Morton R.F., et al. Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22 (2004) 23-30
9. Shimada Y., Yoshino M., Wakui A., et al. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group. J Clin Oncol 11 (1993) 909-913
10. Tournigand C., Andre T., Achille E., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22 (2004) 229-237
11. Llovet J.M., Real M.I., Montana X., et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359 (2002) 1734-1739
12. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
13. Salem R., Thurston K.G., Carr B.I., et al. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 13 suppl (2002) S223-S229
14. Omary R.A., Bettmann M.A., Cardella J.F., et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 13 (2002) 879-881
15. Dancey J.E., Shepard F.A., Paul K., et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 41 (2000) 1673-1681
16. Andrews J.C., Walker S.C., Ackerman R.J., Cotton L.A., Ensminger W.D., and Shapiro B. Hepatic radioembolization with Yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35 (1994) 1637-1644
17. Murthy R., Xiong H., Nunez R., et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16 (2005) 937-945
18. Yu M, Lewandowski RJ, Wong CO, et al. Yttrium-90 (SIR-Spheres®) treatment for metastatic cancer to the liver: midterm results. Presented at the 31st Annual Meeting of the Society of Interventional Radiology; March 31, 2006; Toronto, Canada. Abstract SS03 no. 17; S8.
19. Atassi B, Lewandowski RJ, Mulachy M, et al. Treatment with yttrium-90 microspheres of unresectable metastatic colorectal cancer to the liver: safety, treatment response and survival. Presented at the American Society of Clinical Oncology Gastrointestinal Malignancies Symposium; January 26-28, 2006; San Francisco, CA.
20. Salem R., and Thurston K. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17 (2006) 1251-1278
21. Salem R., and Thurston K. Radioembolization with 90 yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 17 (2006) 1425-1439
22. Salem R., and Thurston K. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 17 (2006) 1571-1593
23. Kaboyashi H., Hidaka H., Kajiya Y., et al. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in ionized oil suspension or of radioactive iodized oil solution. Acta Radiol 27 (1986) 139-147
24. Camma C., Schep F., Orlando A., et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized trials. Radiology 224 (2002) 47-54
25. Brown D.B., Geschwind J.F.H., Soulen M.C., et al. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 17 (2006) 217-223
26. Stuart K., Huberman M., Posner M., et al. Chemoembolization for colorectal metastases. (abstr.). Proc Am Soc Clin Oncol 14 (1995) 190
27. Lang E.K., and Brown C.L. Colorectal metastases to the liver: selective chemoembolization. Radiology 189 (1993) 417-422
28. Sanz-Altamira P.M., Spence L.D., Huberman K.S., et al. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 40 (1997) 770-775
29. Soulen M.C. Chemoembolization of hepatic malignancies. Semin Intervent Radiol 14 (1997) 305-311
30. Voigt W., Brhemann C., Schluter A., et al. A new chemoembolization protocol in refractory liver metastases of colorectal cancer - a feasibility study. Onkologie 25 (2002) 158-164
31. Starkhammar H., Hakansson L., Morales O., and Svedberg J. Intraarterial mitomycin c treatment of unresectable liver tumors: preliminary results on the effect of degradable starch microspheres. Acta Oncol 26 (1987) 295-300
32. Sato K., Lewandowski R.J., Bui J.T., et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29 (2006) 5222-5529
33. Geschwind J., Ramsey D.E., van der Wal B., et al. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Inervent Radiol 26 (2003) 111-117
34. Goin J., Dancey J.E., Roberts C., et al. Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemoembolization versus yttrium-90 glass microspheres. World J Nucl Med 3 (2004) 49-56
35. Van Hazel G., Blackwell A., Anderson J., et al. Randomized phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88 (2004) 78-85
36. Aliberti C., Tilli M., Benea G., and Fiorentini G. Transarterial chemoembolization (TACE) of liver metastases from colorectal from colorectal cancer using irinotecan-eluting beads. Anticancer Res 26 (2006) 3793-3795